A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis

Clinical trial NCT00859105 · COMPLETED

Trial details

NCT number: NCT00859105
Sponsor: Apotex Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2008-02-01
Primary completion: 2008-11-01
Enrollment: 497

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.